Sponsored and organized by:

WHERE INNOVATIVE LIFE SCIENCE COMPANIES

MEET INVESTORS
// Next Edition March 1st-2nd 2022// Euro-Swiss Technopole
//Archamps//France

Company Presentations

Introduction

        Field of Activity
       Selected companies representing the following segments of the life science

       industry will be presenting at BioData.

· Genomics/Proteomics
· Bioinformatics
· Drug Development
· Vaccines
· Pre-IPO
· Medtech
· Tool Companies
· Cancer
· Diabetes

         Duration
       Each presentation will last 15 minutes, including Questions and Answers

How to apply?

A fee of CHF 3’300.- (Euros 2'460.-) will be charged in Swiss Francs, after acceptation of your application, for each company presentation.

This includes:

.A 15 minutes presentation of your Company in plenary session by one of your representative

.Two entrances to BioData2022 with access to all sessions

.Access to 2 sessions a day of one-on-one meetings with investors
.One invitation to the sponsors and speakers dinner
.Company name and link to company website on www.BioDataforum.com
.A 2-page company profile in the participants book that is distributed to all meeting attendees
.Full delegate package
.Coffee break refreshments
.Luncheons

.Networking cocktails

Any additional person wishing to attend the meeting will have to pay the regular participant fee.

If you wish to apply for a company presentation, please complete and send the online company presentation registration form curso decoración de interiores online.

You will receive a response within 10 working days. Selected presenting companies will receive a confirmation letter with all technical and billing details.

Please note that the number of available slots is limited and that the application deadline is postponed to Friday, 11th February 2022.

Register online

Presenting companies (click here to see the schedule)

The registration to select companies is now closed :

there are no more available slots.

The 34 companies selected at BioData2022 are:

                                                    Agenda of the presentations                                                                                 

They will have the opportunities to meet investors coming from the following companies: